Clinical analysis of HPV58-positive cervical cancer
Abstract Objective To study the clinical features of HPV58-positive cervical cancer. Methods A retrospective analysis of 347 patients with HPV58- or HPV16 positive cervical cancer from the Department of Gynecology Tumor of Guangxi Medical University Affiliated Cancer Hospital was performed. Molecula...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-06-01
|
| Series: | Infectious Agents and Cancer |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13027-020-00303-w |
| _version_ | 1818328440164581376 |
|---|---|
| author | Mengjie Chen He Wang Yuejuan Liang Li Li |
| author_facet | Mengjie Chen He Wang Yuejuan Liang Li Li |
| author_sort | Mengjie Chen |
| collection | DOAJ |
| description | Abstract Objective To study the clinical features of HPV58-positive cervical cancer. Methods A retrospective analysis of 347 patients with HPV58- or HPV16 positive cervical cancer from the Department of Gynecology Tumor of Guangxi Medical University Affiliated Cancer Hospital was performed. Molecular hybridization was used to detect HPV genotypes. The clinical features, including age, pathology, and invasion, were compared between the HPV58 positive and HPV16 positive cervical cancer groups. Results A total of 347 patients were eligible for this study, and the proportion of patients who were with poorly differentiated cancer (P = 0.015) was significantly higher in the HPV58 positive group. HPV58 positivity was an independent risk factor for poorly differentiated cancer [HR 2.156, 95% confidence interval: 1.167–3.984, P = 0.014]. The percentage of uterus corps invasion is significantly lower in HPV58 (p = 0.041), but HPV58 positivity is the independent risk factor for uterus corps invasion [HR = 3.985, 95% confidence interval: 1.066–14.893, P = 0.040]. The overall survival of HPV58-positive cervical cancer patients with uterine corpus invasion was significantly lower (P = 0.000). The age of patients in the HPV58-positive cervical cancer at advanced stage was significantly older (P = 0.045). Conclusions HPV58-positive cervical cancer patients are at higher risk of poorly differentiated cancer and uterus corps invasion. The patients with HPV58 positive cervical cancer with uterus corps invasion may result a worse prognosis. |
| first_indexed | 2024-12-13T12:32:12Z |
| format | Article |
| id | doaj.art-2a423f6a6db8464e8228c54062be9170 |
| institution | Directory Open Access Journal |
| issn | 1750-9378 |
| language | English |
| last_indexed | 2024-12-13T12:32:12Z |
| publishDate | 2020-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Infectious Agents and Cancer |
| spelling | doaj.art-2a423f6a6db8464e8228c54062be91702022-12-21T23:45:59ZengBMCInfectious Agents and Cancer1750-93782020-06-0115111010.1186/s13027-020-00303-wClinical analysis of HPV58-positive cervical cancerMengjie Chen0He Wang1Yuejuan Liang2Li Li3Guangxi Medical University affiliated Cancer HospitalGuangxi Medical University affiliated Cancer HospitalGuangxi Medical University affiliated Cancer HospitalGuangxi Medical University affiliated Cancer HospitalAbstract Objective To study the clinical features of HPV58-positive cervical cancer. Methods A retrospective analysis of 347 patients with HPV58- or HPV16 positive cervical cancer from the Department of Gynecology Tumor of Guangxi Medical University Affiliated Cancer Hospital was performed. Molecular hybridization was used to detect HPV genotypes. The clinical features, including age, pathology, and invasion, were compared between the HPV58 positive and HPV16 positive cervical cancer groups. Results A total of 347 patients were eligible for this study, and the proportion of patients who were with poorly differentiated cancer (P = 0.015) was significantly higher in the HPV58 positive group. HPV58 positivity was an independent risk factor for poorly differentiated cancer [HR 2.156, 95% confidence interval: 1.167–3.984, P = 0.014]. The percentage of uterus corps invasion is significantly lower in HPV58 (p = 0.041), but HPV58 positivity is the independent risk factor for uterus corps invasion [HR = 3.985, 95% confidence interval: 1.066–14.893, P = 0.040]. The overall survival of HPV58-positive cervical cancer patients with uterine corpus invasion was significantly lower (P = 0.000). The age of patients in the HPV58-positive cervical cancer at advanced stage was significantly older (P = 0.045). Conclusions HPV58-positive cervical cancer patients are at higher risk of poorly differentiated cancer and uterus corps invasion. The patients with HPV58 positive cervical cancer with uterus corps invasion may result a worse prognosis.http://link.springer.com/article/10.1186/s13027-020-00303-wHuman papilloma virusCervical cancerUterine corpus invasionPrognosis |
| spellingShingle | Mengjie Chen He Wang Yuejuan Liang Li Li Clinical analysis of HPV58-positive cervical cancer Infectious Agents and Cancer Human papilloma virus Cervical cancer Uterine corpus invasion Prognosis |
| title | Clinical analysis of HPV58-positive cervical cancer |
| title_full | Clinical analysis of HPV58-positive cervical cancer |
| title_fullStr | Clinical analysis of HPV58-positive cervical cancer |
| title_full_unstemmed | Clinical analysis of HPV58-positive cervical cancer |
| title_short | Clinical analysis of HPV58-positive cervical cancer |
| title_sort | clinical analysis of hpv58 positive cervical cancer |
| topic | Human papilloma virus Cervical cancer Uterine corpus invasion Prognosis |
| url | http://link.springer.com/article/10.1186/s13027-020-00303-w |
| work_keys_str_mv | AT mengjiechen clinicalanalysisofhpv58positivecervicalcancer AT hewang clinicalanalysisofhpv58positivecervicalcancer AT yuejuanliang clinicalanalysisofhpv58positivecervicalcancer AT lili clinicalanalysisofhpv58positivecervicalcancer |